Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Haase

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Intensive Care Medicine|December 4, 2009
Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illnessSean M Bagshaw, Michael Bennett, Michael Haase, et al.
Seminars in Dialysis|December 2, 2021
Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort studyMichael Haase, Paul Lesny, Anja Haase-Fielitz, et al.
Annals of Laboratory Medicine|February 4, 2021
Predictive Value of Plasma NGAL:Hepcidin-25 for Major Adverse Kidney Events After Cardiac Surgery with Cardiopulmonary Bypass: A Pilot StudyChristian Albert, Michael Haase, Annemarie Albert, et al.
Nephron. Clinical Practice|August 28, 2004
Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experienceStanislao Morgera, Cornelia Scholle, Gitana Voss, et al.
Biomarkers in Medicine|December 20, 2014
The identification of three novel biomarkers of major adverse kidney eventsMichael Haase, Rinaldo Bellomo, Christian Albert, et al.
Biomarkers in Medicine|August 9, 2018
Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgeryChristian Albert, Annemarie Albert, Rinaldo Bellomo, et al.
Journal of Nephrology|January 27, 2022
Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational studyMichael Haase, Paul Lesny, Mark Anderson, et al.
Diseases (Basel, Switzerland)|March 24, 2022
Progression of Chronic Kidney Disease and All-Cause Mortality in Patients with Tricuspid RegurgitationFabian Schipmann, Marwin Bannehr, Valentin Hähnel, et al.
Critical Care (London, England)|August 6, 2011
Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort studyAnja Haase-Fielitz, Peter R Mertens, Michael Plass, et al.
Critical Care Medicine|April 7, 2007
Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patientsMichael Haase, Anja Haase-Fielitz, Sean M Bagshaw, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Intensive Care Medicine|December 4, 2009
Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illnessSean M Bagshaw, Michael Bennett, Michael Haase, et al.
Seminars in Dialysis|December 2, 2021
Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort studyMichael Haase, Paul Lesny, Anja Haase-Fielitz, et al.
Annals of Laboratory Medicine|February 4, 2021
Predictive Value of Plasma NGAL:Hepcidin-25 for Major Adverse Kidney Events After Cardiac Surgery with Cardiopulmonary Bypass: A Pilot StudyChristian Albert, Michael Haase, Annemarie Albert, et al.
Nephron. Clinical Practice|August 28, 2004
Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experienceStanislao Morgera, Cornelia Scholle, Gitana Voss, et al.
Biomarkers in Medicine|December 20, 2014
The identification of three novel biomarkers of major adverse kidney eventsMichael Haase, Rinaldo Bellomo, Christian Albert, et al.
Biomarkers in Medicine|August 9, 2018
Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgeryChristian Albert, Annemarie Albert, Rinaldo Bellomo, et al.
Journal of Nephrology|January 27, 2022
Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational studyMichael Haase, Paul Lesny, Mark Anderson, et al.
Diseases (Basel, Switzerland)|March 24, 2022
Progression of Chronic Kidney Disease and All-Cause Mortality in Patients with Tricuspid RegurgitationFabian Schipmann, Marwin Bannehr, Valentin Hähnel, et al.
Critical Care (London, England)|August 6, 2011
Urine hepcidin has additive value in ruling out cardiopulmonary bypass-associated acute kidney injury: an observational cohort studyAnja Haase-Fielitz, Peter R Mertens, Michael Plass, et al.
Critical Care Medicine|April 7, 2007
Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patientsMichael Haase, Anja Haase-Fielitz, Sean M Bagshaw, et al.
Pageof 17